cardiac arrest News
-
Showcase
Wired: This startup wants to stop deaths from cardiac arrest?
In April 2013, final-year Danish medical student Habib Frost was called out to an emergency: a four-month old girl had just suffered cardiac arrest. Frost’s team tried defibrillation, but to no avail. Immediately after, the team was called out again: another case of cardiac arrest, this time a woman in her 30s. Once again, Frost was powerless to save her life. “I felt ...
By Neurescue
-
Showcase
Neurescue`s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...
By Neurescue
-
1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that
KEY POINTS Cardiac arrest is one of the leading causes of death in the U.S. and globally. It has a survival rate of 1 in 10 people with current treatment. The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest. Cardiac arrest is one of the leading causes of death around the world, ...
By Neurescue
-
Network of Automated External Defibrillators in Poland before the SARS-CoV-2 Pandemic: An In-Depth Analysis
Introduction: Sudden cardiac arrest (SCA), which causes more than half of all cardiovascular related deaths, can be regarded as a common massive global public health problem. Analyzing out-of-hospital cardiac arrest (OHCA) cases, one of the key components is automatic external defibrillators (AEDs). Aim: The aim of this study was to analyze the use and distribution of AEDs in Polish public ...
-
Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company’s Board of Directors
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a clinical-stage medical device company bringing to market the world’s first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. Most recently the regional vice president of Medtronic’s largest sub-region in ...
By Neurescue
-
Location of out-of-hospital cardiac arrests and automated external defibrillators in relation to schools in an English ambulance service region
Introduction: This study sought to identify the availability of automated external defibrillators (AEDs) in schools in the region served by West Midlands Ambulance Service University NHS Trust (WMAS), United Kingdom, and the number of out-of-hospital cardiac arrests (OHCA) that occurred at or near to schools. A secondary aim was to explore the cost effectiveness of school-based defibrillators. ...
-
MFDS Greenlights VUNO Med-DeepCARS, AI Medical Device for Cardiac Arrest Prediction
South Korean artificial intelligence (AI) developer, VUNO Inc. announced today that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest prediction through vital signs. VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that analyzes the potential risk ...
By Vuno Inc.
-
Eg Technology Select Three EIT Health Catapult Winners For Most Innovative Product
As a sponsor of the award, eg have offered a total of 10 days’ worth of engineering expertise, shared amongst the winning three applicants, that can be used towards the realisation of their innovation. The first prize was awarded to Leuko, who will receive five days’ worth of engineering and development support with the eg technology engineering specialists. Leuko have created ...
-
Novel String-Shaped Implantable Defibrillator Proves Effective - In Treating Patients with Irregular Heartbeats
CHICAGO, May 12, 2017 - A new study examines the effectiveness of the Implantable Subcutaneous String Defibrillator (ISSD™), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). This is the first-in-man study to report on the feasibility of the innovative device and was presented today at Heart Rhythm 2017, the Heart Rhythm Society's 38th ...
By NewPace Ltd.
-
Possible Side Effects of Local Anesthesia
Small procedures on the body, like a skin biopsy, are great candidates for local anesthesia. An injection or topical cream may be used. If you’ve ever had an injection by a dentist, you’ve had a local anesthetic. Fast-acting, virtually pain-free and convenient, local anesthetics enable much of medicine to occur. Patients can remain awake and leave following their procedure. After ...
-
Fretting Corrosion Causes Recall of Drug Delivery Medical Device
This past November, the U.S. Food and Drug Administration (FDA) announced a Class 1 recall of the Ikaria INOmax DS Drug Delivery System. The device is a drug delivery system used with ventilators to deliver a preset concentration of INOmax therapy gas (nitric oxide for inhalation) for critically ill patients. According to the FDA posting regarding the recall, “Fretting corrosion at the ...
-
Noleus Wins Gold Prize at Inaugural MassChallenge Houston Accelerator
MassChallenge, a global network of zero-equity startup accelerators, last night named three prize winners from its first Houston-based program: NeuroRescue, Noleous Technologies, and Sensytech. Announced at the MassChallenge Texas in Houston Finale at the House of Blues Houston, this news caps off the first-ever MassChallenge Texas in Houston program, which accelerated 25 of the world’s ...
-
TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool Device for the Treatment of Concussions
TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced complete enrollment status for a clinical trial that began in fall of 2019 using its flagship technology, pro2cool. The pro2cool system is a novel, noninvasive hypothermic therapy device designed to reduce the severity of concussion symptoms and allow patients to return to their ...
-
Mercury Biomed Awarded $1.4 Million
The Ohio Third Frontier Commercialization Acceleration Loan Fund (CALF) has awarded Mercury Biomed a $1.4 million loan to accelerate its efforts in developing and commercializing its patented Smart Temperature Management System™ technology for warming and cooling patients. Mercury Biomed was founded earlier this year as a joint venture between Texas-based CoolCore and Cleveland-based ...
-
TecTraum’s pro2cool Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions
TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool, as a Breakthrough Device. The pro2cool System is a novel, non-invasive hypothermic therapy device designed to reduce the severity of concussion symptoms and allow patients to ...
-
HSC Partners with CardiacSense for medical-grade wearables
CardiacSense is a leading manufacturer of a range of wearable devices for the continuous monitoring of heart arrhythmias and blood pressure HSC signs exclusive Distribution Agreement for Australia & New Zealand for watches & wristbands HomeStay to integrate CardiacSense solutions in HSC’s IoT Platform for assistive technology HomeStay Care Limited (ASX: HSC) ...
By CardiacSense
-
The CardiacSense medical watch receives the Israeli Ministry of Health’s regulatory approval
This is the first medical wristwatch to receive medical regulatory approval for beat by beat heart rate monitoring and A-Fib detection with ECG accuracy The approval allows the company to start selling its medical watch to patients in Israel requiring continuous heart rate monitoring. This enables early detection of Atrial Fibrillation, which can cause severe heart problems, strokes and ...
By CardiacSense
-
CadiacSense unveils Its business model towards beginning of sales in 2020
The Company will enable patients to benefit from Cloud-based medical monitoring, on a monthly fee ”Towards the market entry of our medical wristwatch, the Company is launching a cloud-based service platform dedicated for end-users and their physicians, which will enable patient monitoring as part of their daily routine, in hospitals and in clinics, as well as sharing medical indices with ...
By CardiacSense
-
Professor Gust H. Bardy, M.D. of Bardy Diagnostics Partners with Arrhythmia Alliance to Increase Patient Awareness of Heart Arrhythmias and Early Detection
(Seattle, WA – November 17, 2020) – Chief Medical Officer of Bardy Diagnostics and Clinical Professor of Medicine University of Washington Professor Gust H. Bardy sat down with Trudie Lobban, MBE, Founder and CEO of Arrhythmia Alliance, a non-profit organization dedicated to improving the diagnosis, treatment, and quality of life for all those affected by arrhythmias, to discuss the ...
-
Differences Between Spinal Blocks & Epidurals
The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. The reason for this difference is that the former is an anesthetic, while the latter is an analgesic—no sensation versus no pain. But pain elimination comes with a total lack of feeling in the lower body, due to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you